Molecular genetic and clinical aspects of mitochondrial disorders in childhood

Mitochondrion ◽  
2007 ◽  
Vol 7 (4) ◽  
pp. 241-252 ◽  
Author(s):  
Ali-Reza Moslemi ◽  
Niklas Darin
1996 ◽  
Vol 16 (02) ◽  
pp. 114-138 ◽  
Author(s):  
R. E. Scharf

SummarySpecific membrane glycoproteins (GP) expressed by the megakaryocyte-platelet system, including GPIa-lla, GPIb-V-IX, GPIIb-llla, and GPIV are involved in mediat-ing platelet adhesion to the subendothelial matrix. Among these glycoproteins, GPIIb-llla plays a pivotal role since platelet aggregation is exclusively mediated by this receptor and its interaction with soluble macromolecular proteins. Inherited defects of the GPIIb-llla or GPIb-V-IX receptor complexes are associated with bleeding disorders, known as Glanzmann's thrombasthenia, Bernard-Soulier syndrome, or platelet-type von Willebrand's disease, respectively. Using immuno-chemical and molecular biology techniques, rapid advances in our understanding of the molecular genetic basis of these disorders have been made during the last few years. Moreover, analyses of patients with congenital platelet membrane glycoprotein abnormalities have provided valuable insights into molecular mechanisms that are required for structural and functional integrity, normal biosynthesis of the glycoprotein complexes and coordinated membrane expression of their constituents. The present article reviews the current state of knowledge of the major membrane glycoproteins in health and disease. The spectrum of clinical bleeding manifestations and established diagnostic criteria for each of these dis-orders are summarized. In particular, the variety of molecular defects that have been identified so far and their genetic basis will be discussed.


2018 ◽  
Vol 5 (2) ◽  
pp. 79-84
Author(s):  
Konstantinos Kopsidas ◽  
Hardeep Mudhar ◽  
Karen Sisley ◽  
David W. Hammond ◽  
L. Worthington ◽  
...  

Cell ◽  
1987 ◽  
Vol 48 (5) ◽  
pp. 731 ◽  
Author(s):  
Arthur W. Nienhuis

1995 ◽  
Vol 29 (1) ◽  
pp. 151-178 ◽  
Author(s):  
Nils-Göran Larsson ◽  
David A. Clayton

Author(s):  
Emine Ikbal Atli ◽  
Engin Atli ◽  
Sinem Yalcintepe ◽  
Selma Demir ◽  
Cisem Mail ◽  
...  

Abstract Objective A significant number of genetic variations have been identified in chromosome 22, using molecular genetic techniques. Various genomic disorders on chromosome 22, including cat's eye syndrome caused by extra copies of the proximal region of the 22q chromosome, are now well-defined.Our aim in the study was to show phenotypic variability associated with rearrangements of the 22q chromosomal region. Methods We focused our study on clinical aspects of these disorders, including genetic testing, genotype-phenotype correlation, and potential treatments. A total of 998 patients were referred for genetic analysis (Karyotyping, MLPA, array-CGH) during January 2015 to February 2020 because of intellectual deficiency, behavior issues, and/or multiple congenital abnormalities in several genetics departments. Informed consent was obtained from all the patients and/or their parents. Results 22q11.21 or 22q13.33 microdeletions and 22q11.22-q11.23 microduplication were identified in 31 patients out of referrals. The 22q aberrations were detected in 31/998 patients, giving a prevalence of 3.1%. In this study, 18 patients with 22q11.2 (LCR22A-H) deletion, three patients with 22q13.31 deletion, 9 patients with 22q11.2 duplication and one patient with 22q13.31 duplication were identified. We report on the clinical and molecular characterization of 31 individuals with distal deletions and duplications of chromosome 22q. Conclusions The current study demonstrated in the largest postnatal case series reporting the whole spectrum of atypical phenotypic and genotypic variations at 22q. We believe that when all the phenotypic differences are taken into account, various anomalies including developmental delay and intellectual disability might be considered as an indication to search for aberrations of 22q along with congenital heart diseases.


2021 ◽  
Vol 13 (3) ◽  
pp. 5-18
Author(s):  
M. I. Popkova ◽  
O. V. Utkin ◽  
D. A. Bryzgalova

This review is devoted to the comparative characteristics of human herpesvirus 6A (HHV6A) and human herpesvirus 6B (HHV6B), taking into account their exogenous and endogenous (inherited chromosomally integrated) forms. The analysis of the literature data on the main interspecies differences and intraspecies features of these viruses in molecular-genetic, biological, epidemiological and clinical aspects has been consistently carried out. Modern views about HHV6A and HHV6B, including their unique inherited chromosomal-integrated form, are the basis for organizing a system of epidemiological surveillance of infections caused by these viruses, as well as developing standardized methodological approaches to differential diagnosis, treatment and specific prevention of a wide range of virus-associated diseases. The development of this direction requires a greater evidence base and intensification of joint efforts of the scientific and medical communities.


1992 ◽  
Vol 15 (4) ◽  
pp. 448-455 ◽  
Author(s):  
A. Munnich ◽  
P. Rustin ◽  
A. Rötig ◽  
D. Chretien ◽  
J.-P. Bonnefont ◽  
...  

2001 ◽  
Vol 248 (9) ◽  
pp. 778-788 ◽  
Author(s):  
Monica Sciacco ◽  
Alessandro Prelle ◽  
Giacomo P. Comi ◽  
Laura Napoli ◽  
Alessandro Battistel ◽  
...  

2019 ◽  
Vol 20 (4) ◽  
pp. 952 ◽  
Author(s):  
Michael-Antony Lisio ◽  
Lili Fu ◽  
Alicia Goyeneche ◽  
Zu-hua Gao ◽  
Carlos Telleria

Among a litany of malignancies affecting the female reproductive tract, that of the ovary is the most frequently fatal. Moreover, while the steady pace of scientific discovery has fuelled recent ameliorations in the outcomes of many other cancers, the rates of mortality for ovarian cancer have been stagnant since around 1980. Yet despite the grim outlook, progress is being made towards better understanding the fundamental biology of this disease and how its biology in turn influences clinical behaviour. It has long been evident that ovarian cancer is not a unitary disease but rather a multiplicity of distinct malignancies that share a common anatomical site upon presentation. Of these, the high-grade serous subtype predominates in the clinical setting and is responsible for a disproportionate share of the fatalities from all forms of ovarian cancer. This review aims to provide a detailed overview of the clinical-pathological features of ovarian cancer with a particular focus on the high-grade serous subtype. Along with a description of the relevant clinical aspects of this disease, including novel trends in treatment strategies, this text will inform the reader of recent updates to the scientific literature regarding the origin, aetiology and molecular-genetic basis of high-grade serous ovarian cancer (HGSOC).


Sign in / Sign up

Export Citation Format

Share Document